Rapt Therapeutics (RAPT) PT Lowered to $42 at JPMorgan
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Price: $58.02 --0%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on Rapt Therapeutics (NASDAQ: RAPT) to $42.00 (from $48.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- On Holding AG (ONON)PT Lowered to $42 at Goldman Sachs
- Freedom Broker Upgrades Alico Inc. (ALCO) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
